Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apollo Genetics is a U.S. clinical molecular diagnostics laboratory focused on commercial genetic and infectious disease testing rather than therapeutic drug development. The company operates as part of Apollo Health Group and offers next-generation sequencing and other high-complexity laboratory tests, including hereditary cancer screening, pharmacogenomic testing, carrier screening, respiratory pathogen panels, and other PCR-based assays. Publicly available sources describe Apollo Genetics as a CAP-accredited, CLIA high-complexity laboratory serving clinicians and primary care providers. The business appears to be organized around laboratory services, test commercialization, and provider/patient support rather than a traditional biopharma pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apollo Genetics.